Biotest, a well-known sports supplement company, has introduced a new approach to treating fibromyalgia, a debilitating disease with no known cure that causes stiffness, fatigue, muscle aches, and sleep disturbances, affecting about 10 million Americans, mostly women.
From their website [here]:
Dr. Mike Leahy, of Colorado Springs, has had impressive results by treating fibromyalgia as a metabolic disorder. He believes that fibromyalgia is a disease characterized by the body's inability (or diminished ability) to turn one type of thyroid hormone (T4) into another (T3). (This conversion of T4 into T3 is one of the driving factors behind human metabolism.)
By improving the body's ability to manufacture this vital thyroid hormone through the use of a dietary supplement called Myalgistat, Dr. Leahy has found that 100% of his patients have experienced anywhere from a 50 to 80% improvement in fibromyalgia symptoms.
The main ingredient in Myalgistat is a patent-pending compound called A7-E.™ It's best described as a "metabolism activator." A7-E, along with another patent-pending compound in Myalgistat, GZ™ 100, increases the conversion of T4 to T3 not only in the thyroid, but also throughout the body (much of this desired hormone conversion occurs in muscle tissue, at least in non-fibromyalgia sufferers).
These compounds are completely new to fibromyalgia treatment. Their effects are sustained over 24 hours; they have patents filed on them; they're so effective in their effects on metabolism that there are no other compounds that compare; and they're only found in Myalgistat.
I don't usually plug products from specific companies, but I have personally used Biotest products, and I trust the quality and the research that goes into them. I have had clients in the past who suffered from this disease. If I had access to this supplement at the time, I would have recommended it without hesitation.
No comments:
Post a Comment